Clinical
issues

Explore the intersection of clinical developments and the business of healthcare. From emerging treatments and GLP-1 medications to disease trends, pharmaceutical markets, and drug supply challenges, our insights examine how changes in clinical care influence healthcare costs, patient access, utilization, and organizational strategy.

Clinical issues articles

15 items
Analysis
An exploration of a persistent demographic gap in cardiovascular care (under diagnosis in women) and the way AI is being used to try to close the gap.
Read article
Brandon Aylward
Brandon Aylward
10 min read
Explainers
GLP-1 innovation is reshaping modern medicine, from new drug designs and expanded indications to smarter manufacturing, coverage, and digital integration.
Read article
Brandon Aylward
Brandon Aylward
15 min read
Explainers
Explore specialty value-based care (VBC), the next phase of VBC. Discover how specialty VBC is transforming healthcare with high-quality, cost-effective solutions.
Read article
Jordan Peterson
Jordan Peterson
7 min read
Explainers
This post focused on the intersection between MAHA and the future of preventive care: how the Make America Healthy Again initiative is reshaping primary care and food policy.
Read article
Yulan Egan
Yulan Egan
8 min read
Explainers
The MAHA agenda is advancing quickly. This post covers where the focus has been, and dive into the area that has seen the most action to date: MAHA and vaccines.
Read article
Yulan Egan
Yulan Egan
8 min read
Analysis
This post lays out 5 top ambulatory specialty trends, covering current issues and developments among ambulatory surgery centers (ASCs), infusion centers, and medical groups that perform in-office procedures.
Read article
Amanda Berra
Amanda Berra
9 min read
Analysis
The healthcare industry has been experiencing a wave of vertical consolidation. This post details CVS Health's approach to vertical integration.
Read article
Yulan Egan
Yulan Egan
10 min read
Explainers
Sizing the full, eventual impact of GLP-1s is difficult—here are the eight factors that will determine the size of their impact.
Read article
Yulan Egan
Yulan Egan
7 min read
Explainers
Discover the latest on GLP-1 agonists: from their unprecedented weight-loss effects to potential risks, and more as of August 2024.
Read article
Yulan Egan
Yulan Egan
9 min read

Access more insights. Become a Member.

Go beyond individual insights. Equip your entire organization with a deeper competitive advantage with a Membership. Unlock unlimited research, ongoing education, direct access to industry experts, and the foresight to make smarter, more confident decisions.

Learn more